Lamivudine/zidovudine - Aspen PharmacareAlternative Names: Zidovudine/lamivudine - Aspen Pharmacare
Latest Information Update: 27 Jul 2015
At a glance
- Originator Aspen Pharmacare
- Class Antiretrovirals; Azides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections